Form 4 for ABT Abbott Laboratories
Accepted 2024-04-30 00:00:00 ET · period of report 2024-04-26 · accession 0001415889-24-011796 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-30 | 2024-04-26 | ABT | McKinstry Nancy | Dir | A - Grant | $0.00 | +1,866 | 37.1K | +5% | $0 |
| D | 2024-04-30 | 2024-04-26 | ABT | McKinstry Nancy | Dir | A - Grant | $0.00 | +6,850 | 6,850 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-04-26 | A | A | 1,866 | $0.00 | 37,089 | D | — | — | (F1) These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
| 2 | Derivative | Option (right to buy) | 2024-04-26 | A | A | 6,850 | $0.00 | 6,850 | D | $107.14 · 2024-04-26 to 2034-04-25 | 6,850 Common Shares | (F2) Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |